ACE2 and viral infectious disease: Recent reports have highlighted capture of SARS-CoV-2 virus particles by myeloid cell-specific receptors, such as C-type lectins, or entry of antibody-opsonized virus particles by FcγRs in an ACE2-independent manner, though productive viral infection was not observed [10–12,14,15,34,35].